Evidence map›Paper›PMID 41573495›Full record

ArticleCureus2025

Prevalence and Risk Factors of Urinary Incontinence After Successful Vesicovaginal Fistula Repair.

Saba Bashir, Pulwisha Mustafa, Aasia Nawaz, Sabahat Hamid, Marvi Qazi

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Saba BashirObstetrics and Gynaecology, Isra University Hospital, Hyderabad, PAK.
Pulwisha MustafaObstetrics and Gynaecology, Isra University Hospital, Hyderabad, PAK.
Aasia NawazObstetrics and Gynaecology, Shaikh Zayed Women Hospital, Larkana, PAK.
Sabahat HamidObstetrics and Gynaecology, Lady Dr Asma Arif Maternity Home, Nowshera, PAK.
Marvi QaziObstetrics and Gynaecology, Chandka Medical College Hospital, Larkana, PAK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction Residual urinary incontinence (UI) following anatomically successful vesicovaginal fistula (VVF) repair remains a major postoperative challenge, often compromising quality of life despite surgical closure. Persistent UI arises from a combination of anatomical, obstetric, and sociodemographic influences, which differ across patient populations. Objective The objective of this study is to determine the prevalence and identify the risk factors associated with UI after successful VVF repair. Methods This descriptive study was conducted in the Department of Obstetrics and Gynecology Unit-II, Isra University Hospital, Hyderabad, over 12 months (August 2021 to August 2022). Ninety women who underwent anatomically successful VVF repair were enrolled using nonprobability consecutive sampling. Data regarding demographic, obstetric, and fistula-related variables were collected. Bivariate, stratified, and multivariable logistic regression analyses were performed. Continuous variables were summarized as mean ± SD or median (IQR), and categorical variables as n (%). A p-value <0.05 was considered statistically significant. Results The mean age of participants was 37.04 ± 6.79 years, and the mean BMI was 22.25 ± 2.13 kg/m². Most women were from rural areas (77.8%), illiterate (61.1%), and of low socioeconomic status (73.3%). Postoperative UI occurred in seven (7.78%) women. Among evaluated factors, only fistula type showed a significant association (

Indexed as

anatomical complexityfistula repairpostoperative outcomeurinary incontinencevesicovaginal fistula

Identifiers

PMID41573495
PMCPMC12822847

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.